Literature DB >> 9881777

Selective binding by Helicobacter pylori of leucocyte gangliosides with 3-linked sialic acid, as identified by a new approach of linkage analysis.

L Johansson1, K A Karlsson.   

Abstract

The human gastric pathogen Helicobacter pylori has been shown to bind to glycoconjugates of human leucocytes in a sialic acid-dependent way. In order to improve the identification of the binding epitope, a new technique was developed to analyze the ketosidic linkage position between a terminal sialic acid and the consecutive monosaccharide. Permethylation and reduction with LiAlH4 followed by trifluoroacetolysis in 1000:1 trifluoroacetic anhydride:trifluoroacetic acid (24 h, 100 degrees C) results in the cleavage of glycosidic but not ketosidic bonds. The disaccharide products were analyzed by gas chromatography-mass spectrometry and sialyl-3 or -6 position and NeuAc or NeuGc are identified by their separate retention times and mass spectra. The method was worked out on model saccharides and applied on five-sugar gangliosides (sialylparaglobosides) of human leucocytes. Radiolabeled Helicobacter pylori was shown to bind to the upper part, but not to the lower part, of the five-sugar interval of a mixture of gangliosides separated on a thin-layer chromatogram. Using a membrane blotting procedure the active and inactive bands were isolated and shown to be NeuAcalpha2-3- and NeuAcalpha2-6-paraglobosides, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881777     DOI: 10.1023/a:1006992616254

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  17 in total

Review 1.  Diversity in the sialic acids.

Authors:  A Varki
Journal:  Glycobiology       Date:  1992-02       Impact factor: 4.313

2.  Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies.

Authors:  K A Karlsson
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Carbohydrate composition and sequence analysis of a derivative of brain disialoganglioside by mass spectrometry, with molecular weight ions at m-e 2245. Potential use in the specific microanalysis of cell surface components.

Authors:  K A Karlsson
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

4.  The use of gas chromatography and gas chromatography-mass spectrometry for the characterization of permethylated oligosaccharides with molecular mass up to 2300.

Authors:  H Karlsson; I Carlstedt; G C Hansson
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

5.  Adhesion of Helicobacter pylori strains to alpha-2,3-linked sialic acids.

Authors:  S Hirmo; S Kelm; R Schauer; B Nilsson; T Wadström
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

6.  Screening for the presence of polyglycosylceramides in various tissues: partial characterization of blood group-active complex glycosphingolipids of rabbit and dog small intestines.

Authors:  H Miller-Podraza; G Stenhagen; T Larsson; C Andersson; K A Karlsson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 7.  Microbial recognition of target-cell glycoconjugates.

Authors:  K A Karlsson
Journal:  Curr Opin Struct Biol       Date:  1995-10       Impact factor: 6.809

8.  Application of a simple methylation procedure for the analyses of glycosphingolipids.

Authors:  G Larson; H Karlsson; G C Hansson; W Pimlott
Journal:  Carbohydr Res       Date:  1987-04-01       Impact factor: 2.104

9.  Myeloglycan, a series of E-selectin-binding polylactosaminolipids found in normal human leukocytes and myelocytic leukemia HL60 cells.

Authors:  M R Stroud; K Handa; K Ito; M E Salyan; H Fang; S B Levery; S Hakamori; B B Reinhold; V N Reinhold
Journal:  Biochem Biophys Res Commun       Date:  1995-04-26       Impact factor: 3.575

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.